Adams Share Price (ADA)

[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Adams Plc LSE:ADA London Ordinary Share IM00B986V543 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 9.00 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
8.00 10.00 9.00 9.00 9.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment & Services 2.63 3.18 2.8 7
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 9.00 GBX
Related Shares
Unite (UTG), Grainger (GRI), Dukemount Capital (DKE), Mena Land (MENA)

Adams (ADA) Latest News

Adams News

Date Time Source Headline
26/8/202111:29UKREGAdams PLC Result of AGM
28/6/202113:18ALNCTRADING UPDATES: Croma gains from demand for security guards
28/6/202107:00UKREGAdams PLC Final Results
27/5/202120:17ALNCTRADING UPDATES: Brave Bison, Strix Group see strong performances
27/5/202107:00UKREGAdams PLC Investment in Motif Bio Plc
07/5/202117:51ALNCIN BRIEF: Adams buys 8 million shares in Seeing Machines
07/5/202111:33UKREGAdams PLC Holding(s) in Company
07/5/202111:30UKREGAdams PLC Holding(s) in Company
07/5/202107:00UKREGAdams PLC Investment in Seeing Machines Limited
15/4/202112:48UKREGAdams PLC Result of Open Offer
More Adams News
Adams Investors    Adams Takeover Rumours

Adams (ADA) Discussions and Chat

Adams Forums and Chat

Date Time Title Posts
03/2/202109:27Adams - The Start of Something New90
17/6/202006:08adams46
15/9/201120:15Time to add Adalta Real65
25/6/201110:49Adamind 20071,118
16/11/200818:15Adamind trading at less than cash798

Add a New Thread

Adams (ADA) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Adams trades in real-time

Adams (ADA) Top Chat Posts

DateSubject
25/9/2021
09:20		Adams Daily Update: Adams Plc is listed in the Real Estate Investment & Services sector of the London Stock Exchange with ticker ADA. The last closing price for Adams was 9p.
Adams Plc has a 4 week average price of 9p and a 12 week average price of 8.50p.
The 1 year high share price is 9.93p while the 1 year low share price is currently 6.25p.
There are currently 80,979,876 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Adams Plc is £7,288,188.84.
Read Full Thread
Reply
03/2/2021
09:27		skyship: Resist the temptation to follow into ADA on the current rise to 8p. The rise may well be because of the great performance of their recently acquired holding in C4XD, which gives them a carried paper profit of c£1million. However - look under the bonnet at their other holdings and their performance since the 30th Sept'20 Interims: # CIR - largest holding - N/C # DNL - N/C # DDDD - Down 30% # TALK - Up 20% # GFM - Up 130% - but represents a value increase of just £170k # SBI - Up 50% - but represents a value increase of just £70k At 8p the MCap = £6.6m - not the £3.3m shown on the Quote page! There are 82.55m shares in issue. My estimated current NAV of £5m = 6.0p/share Don't pay a premium for an investment company - especially one controlled as to 77.3% by Richard Griffiths. Perhaps consider a similarly sized investment company on a 40%+ discount & with a current MCap of £5.5m. PRIM @ 4p is backed by 3.5p in cash and another 3.5p in a portfolio of unlisted investments. Looks like a better bet. I declare a holding.
Read Full Thread
Follow
Reply
22/10/2020
15:51		the stigologist: https://www.investegate.co.uk/adams-plc--ada-/rns/investment-commitment-in-c4x-discovery-holdings/202010221023339241C/
Read Full Thread
Follow
Reply
10/6/2020
07:35		vega44: Investment in Oxehealth Limited ("Oxehealth") The Directors announce that, on 9 June 2020, Adams committed to subscribe for 21,630 new ordinary shares of £0.001 in Oxehealth at a price of £26.19 per share for a total cash consideration of £566,489.70 under a subscription agreement dated today ("Subscription Agreement"), which will raise gross subscription proceeds of £5 million for Oxehealth. Settlement of the cash consideration will be by way of payment of £339,893.82 on the first completion date of on or around 10 June 2020, followed by payment of £226,595.88 on the second final completion date of on or around 10 November 2020. The Company's total holding of 21,630 ordinary shares of £0.001 in Oxehealth following the second final completion will represent 2.4% of the issued ordinary share capital of Oxehealth of 903,083 shares at that date. Adams is expected to have remaining cash balances of approximately £240,000 following this investment. Richard Griffiths, who has an interest in 77.3% of Adams' issued share capital, has a current interest in 144,182 Oxehealth shares representing approximately 20.33% of Oxehealth's issued share capital, and Michael Bretherton, Chairman of Adams, holds 1,310 shares in Oxehealth representing 0.18% of its issued share capital. Richard Griffiths is subscribing for 15,274 new ordinary shares in Oxehealth under the Subscription Agreement for a consideration of £400,026 through his controlled undertaking, ORA Limited, and Mr Bretherton is subscribing for 1,528 new ordinary shares in Oxehealth under the Subscription Agreement for a consideration of £40,018. Following full completion of the Subscription Agreement, Mr Griffiths will have a total interest in 181,086 Oxehealth shares, including the Oxehealth shares held by Adams, representing 20.06% of Oxehealth's enlarged share capital. Other substantial shareholders in Oxehealth include the IP Group plc, which is also investing in the current funding round in order to maintain their interest of approximately 35% in Oxehealth's issued share capital held directly and through the IP Venture Fund II. As a result of Michael Bretherton's personal interest in Oxehealth and his directorship of ORA Limited, he took no part in the Board's decision to invest in Oxehealth. About Oxehealth Oxehealth is involved in vision-based patient monitoring and management, using proprietary signal processing and computer vision to process normal digital video camera data to measure the vital signs and activity of patients. This is achieved through the deployment of their Digital Care Assistant (DCA) platform which consists of a fixed installation camera and illuminator, monitoring screens and software modules including the Vital Signs module, a Class IIa medical device cleared in Europe which represents a global first for a software. The platform enables clinicians to take non-contact cardiorespiratory measurements of patients' pulse and breathing rate, generates alerts to potentially risky activity and reports on patients' vital signs and behaviour, all without the clinician entering the patient's room. The system offers measurable benefits in helping clinicians to improve the safety of both patients and carers. Since its commercialisation in 2018, the DCA been deployed into a number of different markets, primarily in Mental Health, Acute Hospital settings, Primary Care settings, Care Home, and Custodial facilities in both the UK and now in Sweden. Since launch, the DCA has achieved significant traction, being deployed in 30% of all NHS England Mental Health Trusts. These partners have seen improvements in safety, quality and efficiency, with recent data* demonstrating: · 48% reduction in falls in dementia facility · 68% reduction in A&E visits from the dementia facility · 49% reduction in emergency service visits · 71% reduction in spend on enhanced observations Recently, Oxehealth has reported that clinicians have made increasing use of the Oxehealth Service when caring for patients with COVID-19, both in Mental Health and also in Primary Care settings (General Practitioner COVID-19 Triage Hubs), due to its ability to limit clinician to patient contact whilst helping to maintain patient safety remotely. With non-contact monitoring becoming increasingly important and clinically relevant, Oxehealth plans to further expand into Europe and North America. The last filed accounts for Oxehealth are for the year ended 31 December 2018 and include a loss after tax of approximately £2.8 million, reflecting the continued significant investment in development and marketing in that year. Barney Quinn, Chairman of Oxehealth, commented: "We would like to thank Adams Plc for contributing to the current successful funding round. The investment shows the faith in the Oxehealth Digital Care Assistant and the measurable benefits it brings to patients, clinicians and managing healthcare budgets. The investment funds will help Oxehealth on its continued expansion in the UK and internationally." Further information on Oxehealth is available on the Oxehealth website www.oxehealth.com. Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement. *Source data published in early 2020 by Coventry & Warwickshire Partnership NHS Trust with support from Oxehealth following an 8 month clinical study on the impact of using the Digital Care Assistant (DCA) on their dementia wards.
Read Full Thread
Follow
Reply
20/9/2015
16:35		hedgehog 100: 18/09/2015 07:00 UKREG Adams PLC Issue of Equity " ... The Company is pleased to announce that its broker, Peterhouse Corporate Finance Limited, has co-ordinated a conditional placing of 18,181,818 new ordinary shares of EUR0.01 each ("Placing Shares"), representing 44 per cent. of the enlarged issued share capital of the Company, with new and existing investors at a placing price of 4.4p per ordinary share to raise GBP800,000 for the Company before expenses (the "Placing"). The proceeds of the Placing will be used make investments in accordance with the Company's investing policy and for general working capital purposes. ... Application has been made for the 18,181,818 new ordinary shares to be admitted to trading on AIM. Admission is expected to occur on or around 23 September 2015. ... For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital following the placing will be 41,276,616 ordinary shares. ..." http://uk.advfn.com/news/UKREG/2015/article/68561865 Glavey, You're being too generous. The placing at 4.4p was actually a 63.33% discount to the pre-existing share price of 12p. Strange that the price rose on Friday: Price Price Change [%] Bid Offer Open High Low Volume 0.15 0.025 [20.83] 0.12 0.17 0.11 0.15 0.11 12,586 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range 3.35 23.09 3.19 -0.10 - - - 0.23 - 0.11 The new market cap. at the current price would be about £6M.
Read Full Thread
Follow
Reply
20/9/2015
03:06		glavey: Issue of Equity. Really wonderful how all these related party transactions are just passed off as fair and reasonable at a 50% discount to current share price when it represents a near 80% dilution for those not invited to participate. Last year they flogged off a few assets and gave themselves a bung to mop up the returns. If they want to run it as a private fiefdom why not make an offer to buy out the other shareholders.
Read Full Thread
Follow
Reply
22/1/2015
18:06		rbcrbc: http://www.investegate.co.uk/adams-plc--ada-/rns/holding-s--in-company/201501221503329196C/ Mr David H Richardson increasing his stake through 15-23% today but no price change - is something about to happen ?
Read Full Thread
Follow
Reply
17/9/2014
10:09		skier100: ADA is a 6-bagger in 2 hours today. Well done to all the investors with quick fingers who made money here today. Well done to all the ADA investors who ignored the derampers in the past few days. With a new investment on the way, a famous big investor onboard with a 28% stake (Richard Griffiths), and a tiny 8m free-float of shares, ADA is undergoing a major rerating.
Read Full Thread
Follow
Reply
16/9/2014
22:14		skier100: ADA's shareprice 6-bagged between Mar 2013 and Oct 2013 in anticipation of ADA spending its new funds and backing in a new investment. ADA, right now, in Sep 2014, is once again at the point in its cycle where it has new funds coming in, a famous investor with a 28% stake, and the Board is discussing a new investment. New money + new investment + new news = rerating for ADA...
Read Full Thread
Follow
Reply
16/9/2014
16:38		skier100: Praipus -- Take a look at the 3 funding RNSs ADA released in Sep 2014. ADA is sitting on far more cash now than this time last year. The Board is also looking at a new investment to back into ADA. And as you rightly pointed out, Richard Griffiths and Ora Capital Partners now have a 28% stake in ADA. Such a famous investor would not take such a big stake in ADA if he didn't think / know something was cookin' here.
Read Full Thread
Follow
Reply
16/9/2014
14:58		skier100: ADA is now ready for takeoff. Presently offering a tiny marcap under £1m, ADA is sitting on spare cash and reviewing currently a new investment to back into (RTO into a shell). ADA has a miniscule free float of just 8 million shares on AIM. Once ADA moves, it will move fast. Investors will be aware that EMT 50-bagged and CHA 10-bagged in anticipation of new shell investments this year.
Read Full Thread
Follow
Reply
Adams share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
ADA
Adams
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210925 10:56:29